ATLANTA, GA, UNITED STATES, November 19, 2025 /EINPresswire.com/ -- The Open Applications Group, Inc. (OAGi) and the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) are proud to announce the release of a groundbreaking set of ontologies designed to enhance data interoperability and analytics capabilities across the biopharmaceutical industry. These ontologies are the result of a collaborative effort within OAGi’s Industrial Ontologies Foundry (IOF) among domain experts, standards developers, and leading organizations. They establish a semantic foundation for consistent data exchange, integration, and interpretation.

The newly released ontologies cover core biomanufacturing concepts including process parameters, equipment, quality attributes, various types of recipes and their components, processing steps and materials. They are intended to serve as a common reference framework for systems integration, data analytics, regulatory submissions, and digital transformation initiatives across the biopharmaceutical manufacturing value chain.

Roger Hart, NIIMBL Senior Fellow and Big Data Program Lead, stated:

“Ontologies give us a shared language to structure and contextualize manufacturing data. With this release, we’re one step closer to seamless interoperability across our systems, suppliers, and regulators. With this release we see growing progress toward cross-consortia collaboration to create an interoperable ontology to serve the biopharmaceutical manufacturing industry.”

Boonserm Kulvatunyou, NIST Process Engineering Group Leader and Semantics Interoperability Expert, commented:

“This joint initiative marks a significant milestone in our mission to bring a new, advanced data interoperability standard to bring new values to industries. The ontologies we’ve co-developed with OAGi and NIIMBL members will empower the industry to create smarter automations, better traceability, and more scalable and reliable analytics and AI.”

Elyse Easson, Director, Commercialization and Digital CMC Value Team/Digital MMD stated:

“This latest release of ontologies is a significant step forward in establishing industry-wide standards for biopharmaceutical manufacturing digitalization. The enhanced ontology features streamlined conceptual frameworks and refined semantic constructs that dramatically improve usability for ontology specialists and implementation teams.”

Jan Kemper, Associate Principal Automation Engineer, AstraZeneca added:

“This ontology will be beneficial to the development of biopharmaceuticals because it will facilitate communication amongst those with diverse backgrounds. The human-readable aspects of it provide a shared language and reference point for effective communication between organizations. The machine- readable aspects will enable automated organization and visualization of data from disparate sources, a task that is frequently time consuming and performed manually.”

Markus Hartmann, Global Product Lead for Data Semantics, MilliporeSigma commented:

“This latest release of biopharmaceutical manufacturing ontologies is a significant step forward, establishing a shared language for data across the industry. By creating a standardized, streamlined framework, these ontologies provide the clean, well-structured data essential for analytics and AI to thrive. This unification of data from diverse sources not only ensures seamless interoperability but also accelerates insights that improve product quality, yield, and time to market.”

The ontologies are now publicly available under an MIT-style license and are expected to be adopted by other standard development organizations as a basis for their ontologies and by technology vendors, regulatory bodies, and biomanufacturing organizations seeking to modernize their data infrastructure and promote digital maturity.

For access to the ontologies and technical documentation, visit www.oagi.org/BMIC

Michelle Banks
Open Applications Group , Inc
+1 404-402-1962
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact [email protected]